As a result, combining CSF lysosomal markers with CSF α-Syn aggregates or any signs of mitochondrial impairment, neuroinflammation, or other pathogenic proteins in PD may allow for a more definitive diagnosis [296]. The gene discussed is CSF2; the disease is Parkinson disease.